Current trends in the course, treatment, and outcomes of ST-segment elevation myocardial infarction (STEMI) in patients with COPD.

K. Klester (Barnaul, Russian Federation), E. Klester (Barnaul, Russian Federation), A. Balitskaya (Barnaul, Russian Federation), I. Sheremetyeva (Barnaul, Russian Federation), V. Elykomov (Barnaul, Russian Federation), M. Alwash (Yoshkar-Ola, Russian Federation)

Source: Virtual Congress 2020 – COPD phenotypes
Session: COPD phenotypes
Session type: E-poster session
Number: 2446
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Klester (Barnaul, Russian Federation), E. Klester (Barnaul, Russian Federation), A. Balitskaya (Barnaul, Russian Federation), I. Sheremetyeva (Barnaul, Russian Federation), V. Elykomov (Barnaul, Russian Federation), M. Alwash (Yoshkar-Ola, Russian Federation). Current trends in the course, treatment, and outcomes of ST-segment elevation myocardial infarction (STEMI) in patients with COPD.. 2446

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparative analysis of global longitudinal strain in patients with ST-segment elevation myocardial infarction (STEMI) with and without concomitant COPD.
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019

Prognostic value of right ventricular systolic dysfunction in patients with chronic obstructive pulmonary disease after ST-segment elevation myocardial infarction (STEMI).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Heart remodeling in patients after St-segment elevation myocardial infarction with and without concomitant COPD.
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020


COPD and acute myocardial infarction
Source: Eur Respir Rev, 29 (156) 190139; 10.1183/16000617.0139-2019
Year: 2020



The impact of tobacco cessation on the evolution of patients with non-ST-elevation acute coronary syndromes.
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018

High coincidence of COPD with increased mortality in an unselected group of Danish patients with acute myocardial infarction
Source: Eur Respir J 2005; 26: Suppl. 49, 218s
Year: 2005

Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD
Source: Eur Respir J 2012; 39: 1097-1103
Year: 2012



Myocardial infarction, heart failure and mortality in patients with COPD in primary care.
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study.
Source: International Congress 2019 – More and more COPD
Year: 2019


Clinical features of hospital-aquired pneumonia in patients with myocardial infarction
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008


Effect of COPD on immediate and long-term outcomes of STEMI.
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Exacerbation frequency and increased risk of myocardial infarction in COPD
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008

Beta-blocker use is associated with lower mortality following myocardial infarction in patients with and without COPD. A Danish nationwide cohort study.
Source: International Congress 2019 – More and more COPD
Year: 2019


Sleep quality of patients with acute myocardial infarction outside the CCU environment
Source: Eur Respir J 2006; 28: Suppl. 50, 633s
Year: 2006

Smoking status and in-hospital outcomes of ST elevation myocardial infarction patients in a Brazilian public university hospital
Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence
Year: 2020


The prevalence of COPD in patients participated in rehabilitation program after myocardial infarction
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


Beta-blocker, aspirin and statin usage after myocardial infarction in patients with and without COPD. A nationwide analysis from 1995 to 2015 in Denmark
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018



OSA and myocardial infarction
Source: ERS Conference
Year: 2015

Pattern of risk of myocardial infarction (MI) in patients taking asthma medication: a study with the UK general practice research database (GPRD)
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009


COPD in patients evaluated for stable myocardial ischemia – observational study
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018